Invesco Health Care C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invesco Health Care Fund Class C GTHCX
- NAV / 1-Day Return 17.96 / +0.45 %
- Total Assets 1.2B
-
Adj. Expense Ratio
1.820%
- Expense Ratio 1.810%
- Distribution Fee Level Below Average
- Share Class Type Level Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 59%
USD | NAV as of Oct 08, 2026 | 1-Day Return as of Oct 08, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GTHCX
Will GTHCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 10.59 | 128M | Healthcare |
Johnson & Johnson | 6.76 | 82M | Healthcare |
UnitedHealth Group Inc | 6.17 | 74M | Healthcare |
Merck & Co Inc | 4.59 | 55M | Healthcare |
AbbVie Inc | 4.03 | 49M | Healthcare |
Gilead Sciences Inc | 3.63 | 44M | Healthcare |
argenx SE ADR | 2.99 | 36M | Healthcare |
CVS Health Corp | 2.52 | 30M | Healthcare |
Welltower Inc | 2.34 | 28M | Real Estate |
BrightSpring Health Services Inc | 2.20 | 27M | Healthcare |